On the deal, Doc Generici is supported by Bird&Bird for the legal aspects, by Latham & Watkins for the financial ones and by PedersoliGattai for the...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi announced the sale of 2 portfolios of products for central nervous systems disorders and pain and vascular diseases to...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi announced the sale of a portfolio made up of eight anti-infectives including Azactam™, Cefotax™, Claforan™, Oroken™, Rulid™, Suprax™, Wintriaxone™ and...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. SUBSTIPHARM, a privately held pharmaceutical group, announced the acquisition of the Japanese Encephalitis vaccine IMOJEV from Sanofi. Sanofi operates as...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi announced the sale of a portfolio of pharmaceutical products to Cheplapharm Arzneimittel GmbH, a German privately-owned company headquartered in...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dentons, Jones Day, advised on the matter. Dentons advised Septodont with a team including Jean-Marc Grosperrin (Corporate M&A), Loc Lemercier (IP&IT), Emmanuelle van den...
You must be a Standard 1 Year member to access this content.
